Jakarta, 30 October 2025 – i3L University (formerly Indonesia International Institute for Life Sciences) proudly celebrates apt. Annisa Fatharani, S.Farm., M.Sc, lecturer in the Pharmacy Department, who has won the Best Poster Award at the 11th Asian Conference on Tumour Ablation (ACTA 2025), along with two other delegates from Japan and Taiwan.

Held from October 25-27, 2025 at The Grand Hotel in Taipei, Taiwan, ACTA 2025 gathered leading experts in interventional oncology and tumour ablation from across Asia and beyond. The conference served as a platform to exchange the latest advances in cancer ablation and therapy, including image-guided therapy, artificial intelligence, robotic navigation, and combined treatment approaches for various tumour types, such as hepatobiliary, thoracic, and musculoskeletal cancers. A hands-on pre-conference workshop on October 24 also allowed participants to train directly with different ablation techniques, including radiofrequency, microwave, and cryoablation, under expert guidance.

Annisa’s winning poster, titled “Interactive Web-Based Platform for Automated Microscopy Analysis of Cytotoxic Effects in Tumour Co-Culture Models,” introduced Cellscope; an open-source, browser-based application designed to make image-based in vitro cytotoxicity analysis easier and more accessible to researchers in small labs.

Cellscope allows users to automatically analyse microscope images of tumour cell cultures and measure how treatments affect cell death or survival. By applying image-processing algorithms written in Python, the platform quantifies morphological changes, key indicators of cytotoxicity assessment in co-culture models. The system produces efficient, reproducible data that help researchers evaluate treatment responses objectively, without relying on manual observation.

Because it runs entirely on a web browser, Cellscope removes the need for costly commercial software or high-end computing equipment. This makes it especially valuable for smaller or resource-limited laboratories that wish to perform high-content image analysis with reliable accuracy.

“I feel incredibly honoured to receive this award at ACTA 2025,” said Annisa. “We (with the collaborator from the University of Strathclyde, UK) developed Cellscope to help researchers who may not have access to expensive analysis platforms. It is rewarding to see how this project can support wider collaboration and empower more people in the cancer research community.”

Beyond this achievement, Annisa’s work reflects her broader commitment to integrating research innovation with education. With a background in Clinical Pharmacology from King’s College London, and earlier degrees in Pharmacy from Universitas Andalas and Apothecary training from Universitas Indonesia, she brings both an international perspective and local passion into her academic role.

At i3L, she continues to bridge pharmacological science with digital and data-driven approaches, mentoring students to explore how technology can enhance discovery in drug development and personalized medicine. Her success at ACTA 2025 highlights the growing importance of interdisciplinary research in life sciences and demonstrates how creative, accessible tools like Cellscope can make a global impact right here in Indonesia.

“This award motivates me to keep developing solutions that make research more inclusive and collaborative,” Annisa added. “I hope it also inspires students to see that science and technology go hand in hand, and that innovation can start from anywhere, from an interdisciplinary perspective.”